Celltrion, Inc.

068270 KRX Pharmaceuticals Pharmaceuticals
KOSPI
₩178,200.00
-1.44%
Delayed · cached 15 min

Fair value analysis

068270
Celltrion, Inc.
PharmaceuticalsPharmaceuticals
₩178,200.00
Close used for this calculation
₩93,630.13Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
55/100
Profitability25/25
Returns3/25
Balance Sheet19/25
Efficiency8/25
Growth12/25
Good
Quality radar
55Prof.25/25Ret.3/25Eff.8/25B.Sht19/25Growth12/25

Consensus fair value

₩93,630.13
Above FV
▼ -47.5% against the close used
Model range ₩47,152.04 – ₩301,864.00
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩47,152.04Fair value₩93,630.13Bull₩301,864.00
FairClose
52-week traded range
52W low ₩159,400.0052W high ₩236,666.67

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Celltrion, Inc. closed at ₩178,200.00, 90.3% above the consensus fair value of ₩93,630.13 drawn from 9 valuation models.

Financial DNA score 55/100 — Good. P/E of 38.2x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩48,311.44
-72.9%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₩91,003.13
-48.9%
√(22.5 × EPS × BVPS)
EPS=4668, BVPS=78849.56 · outside Graham range (P/E 38.2, P/B 2.3) — asset-light, treat as a rough floor
Graham Formula
₩301,864.00
+69.4%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=20%, FD=3.3%
P/E Fair Value
₩93,360.00
-47.6%
EPS × 20x (sector P/E)
EPS=4668, Sector P/E=20x
Peter Lynch (PEG)
₩106,243.68
-40.4%
EPS × Growth% (PEG = 1 is fair)
EPS=4668, g=22.8%
EV/EBITDA
₩95,182.92
-46.6%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=1.17T
Book Value (P/B)
₩47,152.04
-73.5%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=78849.56, ROE=6%, g=6%, r=10%
Reverse DCF
₩178,200.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 15.9% | Historical: 22.8%
Margin of Safety
₩100,225.98
-43.8%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=133634.64, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.